Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Nanoparticle Gold-Filled Silicon Wafers Effectively Kill Breast Cancer Cells

By BiotechDaily International staff writers
Posted on 02 Feb 2012
Heat generated when hollow gold nanoparticles embedded in silicon nanowafers were exposed to infrared light effectively killed breast cancer cells in vitro and in a mouse model.

Investigators at The Methodist Hospital Research Institute (Houston, TX, USA) created the highly efficient thermal transfer nanoparticles by confining gold nanoshells into nanopores of silicon microparticles. In the presence of infrared light at 808 nm, the gold-filled silicon particles heated up a surrounding aqueous solution by about 20 °C in seven minutes.

Hollow gold responds to near-infrared (NIR) light, which is able to penetrate deeply inside the body and which causes less damage to tissues compared to shorter wavelength light due to less absorbance by the tissue chromophores.

The investigators used human and mouse breast-cancer lines to test cell killing in vitro and the mouse model of 4T1 mammary tumor for in vivo studies. They reported in the January 3, 2012, online edition of the journal Advanced Healthcare Materials that the nanoparticles effectively killed cancer cells both in vitro and in the mouse model.

“Hollow gold nanoparticles can generate heat if they are hit with a near-infrared laser,” said first author Dr. Haifa Shen, assistant research member at The Methodist Hospital Research Institute. “Multiple investigators have tried to use gold nanoparticles for cancer treatment, but the efficiency has not been very good – they would need a lot of gold nanoparticles to treat a tumor. We found that heat generation was much more efficient when we loaded gold nanoparticles into porous silicon, the carrier of the multistage vectors.”

“The hollow gold particles we load into the porous silicon must be the right size and have the correct-sized space inside them to interact with the infrared light we are using,” said Dr. Shen. “But the wavelength of infrared we use will have to change depending on where the tumor is. If it is close to the skin, we can use shorter wavelengths. Deeper inside the body, we have to use longer wavelengths of infrared to penetrate the tissue. The hollow space of the gold particles must be modified in response to that. We are planning preclinical studies to study the technology's impact on whole tissues, breast cancer cells, and possibly pancreatic cancer cells. We would also like to see whether this approach makes chemotherapy more effective, meaning you could use less drugs to achieve the same degree of success in treating tumors. These investigations are next.”

Related Links:

The Methodist Hospital Research Institute


comments powered by Disqus

Channels

Drug Discovery

view channel

Ibuprofen May Restore Immune Function in Older Individuals

New research suggests that macrophages from the lungs of old mice respond differently to infections than those of young mice, and ibuprofen given to the mice reversed these changes. New research using lab mice suggests that the solution to more youthful immune function might already be a common over-the-counter pain reliever.... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel
Image: Leica Microsystems launches the inverted research microscope platform Leica DMi8 (Photo courtesy of Leica Microsystems).

New Inverted Microscope Designed to Readily Adapt to Changing Research Demands

A new inverted microscope for biotech and other life science laboratories was designed to readily accommodate modifications and upgrades to allow it to keep current with changing research demands and interests.... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.